1 – 10 of 80
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- EuroInf 2 : Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
- 2018
- 11C-PE2I and 18F-Dopa PET for assessing progression rate in Parkinson's : A longitudinal study
- 2017
- Factors associated with perceived walking difficulties in people with Parkinson’s disease
- Clinical diagnosis of progressive supranuclear palsy : The movement disorder society criteria
- PBB3 imaging in Parkinsonian disorders : Evidence for binding to tau and other proteins
- Increased basal ganglia binding of 18F-AV-1451 in patients with progressive supranuclear palsy
- 2016
- Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
- Gray and white matter imaging : A biomarker for cognitive impairment in early Parkinson's disease?
- Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease
- Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression